It comprised adults with T2D who had discontinued an oral glucose-lowering medication or were treatment-nave
Carrillo-Beltrn D, Osorio JC, Blanco R, Oliva C, Boccardo E, Aguayo F
Retatrutide is an investigational triple receptor agonist (GLP-1, GIP, and glucagon) currently in clinical trials for obesity and type 2 diabetes
NNMT inhibition produces metabolic effects including increased NAD+ levels and reduced lipogenesis
Some consider that the hypothesis of 'multiple parallel strikes' could be an improved explanation of the causes of MASLD development and these strikes included oxidative stress, endoplasmic reticulum (ER) stress, lipid metabolism disorders, abnormal adipokines and cytokines production and mitochondrial dysfunction (15)
Additionally, some individuals taking Mounjaro may have pre-existing conditions that independently increase their risk of B12 deficiency, such as previous bariatric surgery or concurrent metformin use (the MHRA has highlighted that metformin can reduce vitamin B12 levels)